These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial. Sarsenbayeva G; Volgin Y; Kassenov M; Issagulov T; Bogdanov N; Sansyzbay A; Abitay R; Nurpeisova A; Sagymbay A; Koshemetov Z; Stukova M; Buzitskaya Z; Кulmagambetov I; Karabayeva D; Davlyatshin T; Khairullin B J Med Virol; 2018 Jan; 90(1):41-49. PubMed ID: 28842994 [TBL] [Abstract][Full Text] [Related]
25. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial. Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857 [TBL] [Abstract][Full Text] [Related]
26. [Vaccination against influenza in pregnant women - safety and effectiveness]. Nitsch-Osuch A; Woźniak Kosek A; Brydak LB Ginekol Pol; 2013 Jan; 84(1):56-61. PubMed ID: 23488311 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Neuzil KM; Dupont WD; Wright PF; Edwards KM Pediatr Infect Dis J; 2001 Aug; 20(8):733-40. PubMed ID: 11734733 [TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women. Munoz FM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Stephens I; Ault K; Winokur P; Petrie CR; Wolff M; Patel SM; Keitel WA Vaccine; 2018 Dec; 36(52):8054-8061. PubMed ID: 30416018 [TBL] [Abstract][Full Text] [Related]
29. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. Masurel N; Laufer J J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638 [TBL] [Abstract][Full Text] [Related]
30. A randomized, controlled trial in children to assess the immunogenicity and safety of a thimerosal-free trivalent seasonal influenza vaccine. Domachowske JB; Blatter M; Chandrasekaran V; Liu A; Jain VK; Fries L Pediatr Infect Dis J; 2012 Jun; 31(6):605-15. PubMed ID: 22333695 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age. Vesikari T; Block SL; Guerra F; Lattanzi M; Holmes S; Izu A; Gaitatzis N; Hilbert AK; Groth N Pediatr Infect Dis J; 2012 May; 31(5):494-500. PubMed ID: 22301476 [TBL] [Abstract][Full Text] [Related]
38. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses. van de Witte S; Nauta J; Montomoli E; Weckx J Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447 [TBL] [Abstract][Full Text] [Related]
39. Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study. Tregnaghi MW; Stamboulian D; Vanadía PC; Tregnaghi JP; Calvari M; Fragapane E; Casula D; Pellegrini M; Groth N Viral Immunol; 2012 Jun; 25(3):216-25. PubMed ID: 22691101 [TBL] [Abstract][Full Text] [Related]
40. Influenza vaccination during pregnancy and its usefulness to mothers and their young infants. Takeda S; Hisano M; Komano J; Yamamoto H; Sago H; Yamaguchi K J Infect Chemother; 2015 Apr; 21(4):238-46. PubMed ID: 25708925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]